Position in AMRN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$79
+$7 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 80 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. AMRN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,490 | $1,347,965 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
|
3,263 | $828,704 | |
| 4 | ABBV |
AbbVie Inc.
|
2,981 | $750,138 | |
| 5 | AMGN |
Amgen Inc
|
1,376 | $498,277 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,950 | $458,079 | |
| 7 | PFE |
Pfizer Inc
|
13,048 | $314,195 | |
| 8 | AZN |
Astrazeneca PLC
|
967 | $183,362 |
All Filings in AMRN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79 | 5 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $72 | 5 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $69 | 5 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $81 | 5 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $81 | 5 | Shares | Sole | 2025-07-30 | |
| 2024-12-31 | $49 | 100 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||